1. Market Research
  2. > Therapy
37 reports for Salicylic Acid (page 1)

Purchase Reports From Reputable Market Research Publishers

Global Psoriasis Treatment Market - Analysis By Type, By Treatment Method, By Region, By Country (2020 Edition): Market Insights and Outlook Post Covid-19 Pandemic (2020-2025)

  • $ 1800
  • July 2020
  • 180 pages

salicylic acid, Steroids (corticosteroids), Retinoids, Anthralin, Vitamin D analogue, moisturizer The market of topical treatment is expected to attain the market value of USD ## Million in 2025 from USD ##. ## in 2019 with and emollients which are used to cure mild to moderate psoriasis

  • Autoimmune Disease
  • Pathology
  • Salicylic Acid
  • Therapy
  • Amgen Inc.

Vaginal Cancer - Pipeline Review, H1 2020

  • $ 2000
  • May 2020
  • 381 pages

Vaginal Cancer - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Vaginal Cancer – Pipeline Review, H1 2020, provides an overview of the Vaginal Cance ...

  • Lung Cancer
  • Sexually Transmitted Disease
  • North America
  • United States
  • Amgen Inc.

Global Cardiovascular Disease Drugs Market to 2023 - Expiries, Acquisitions and New Products for Deep Vein Thrombosis, Pulmonary Arterial Hypertension and Dyslipidemia to Shake-Up the Competitive Landscape

  • $ 4995
  • December 2017
  • 228 pages

Bayer has several products indicated within CVD, including Aspirin Cardio (aspirin).

  • Cardiovascular Disease
  • Chronic Disease
  • Pathology
  • Salicylic Acid
  • Amgen Inc.

Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs

  • $ 4995
  • March 2018
  • 148 pages

In APAC, it is marketed in Japan, Australia, China, India and South Korea. ##. ##. ## HYDROXYCHLOROQUINE ##. ##. ## LEFLUNOMIDE ##. ##. ## SULFASALAZINE ##. ##. ## CYCLOSPORINE ##. ##. ## XELJANZ (TOFACITINIB) ##. ##. ## OTHER NON-BIOLOGICS ##. ##. ##. ## Non-steroidal Anti-inflammatory Drugs NSAIDs such as aspirin, diclofenac

  • Clinical Trial
  • Monoclonal Antibody
  • Salicylic Acid
  • Therapy
  • Amgen Inc.

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2020

  • $ 2000
  • April 2020
  • 403 pages

Aspirin and Rintatolimod With or Without Interferon-alpha ##b in Treating Patients with Prostate Cancer Before Surgery (NCT NCT## - authorized by the FDA and Roswell Park s Internal Review Board; not yet recruiting), and Chemokine Modulation Therapy and Pembrolizumab in Treating Partic

  • Lung Cancer
  • Pharmaceutical
  • Salicylic Acid
  • Therapy
  • Amgen Inc.

Vaginal Cancer - Pipeline Review, H2 2019

  • $ 2000
  • December 2019
  • 351 pages

Aspirin and Rintatolimod With or Without Interferon-alpha ##b in Treating Patients with Prostate Cancer Before Surgery (NCT NCT## - authorized by the FDA and Roswell Park s Internal Review Board; not yet recruiting), and Chemokine Modulation Therapy and Pembrolizumab in Treating Partic

  • Cancer
  • Lung Cancer
  • Salicylic Acid
  • United States
  • Amgen Inc.

Global Pain Therapeutics Market to 2023 - Innovative New Products to Address Unmet Need within Chronic Pain and Migraine, and Tackle Opioid Abuse

  • $ 4995
  • June 2017
  • 1 pages

Other NSAIDs - such as ibuprofen and aspirin - non-selectively inhibit COX enzymes, inhibiting the role of COX-## in the protection of GI mucosa and kidney hemodynamics, and in thrombosis formation.

  • Pain Relief
  • Pharmaceutical
  • Salicylic Acid
  • Therapy
  • Amgen Inc.

PharmaPoint: Migraine - Global Drug Forecast and Market Analysis to 2026

  • $ 10995
  • August 2017
  • 262 pages

" In my opinion, triptans are safer in long-term treatment compared to anti-inflammatory drugs because we know that chronic anti-inflammatory drugs used when they' re not taking aspirin may increase cardiovascular risk.

  • Antimigraine
  • Pain Relief
  • Salicylic Acid
  • Therapy
  • Amgen Inc.

The Biopharmaceutical Industry in 2017: Highlights by Therapeutic Area

  • $ 275
  • February 2018
  • 50 pages

The Biopharmaceutical Industry in 2017: Highlights by Therapeutic Area Summary GlobalData’s "The Biopharmaceutical Industry in 2017: Highlights by Therapeutic Area", provides an insight-rich overview ...

  • Therapy
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Eli Lilly & Co.

Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2018-2025

  • $ 3499
  • August 2018
  • 340 pages

Roots Analysis: According to you, what is the opportunity for non-opioid analgesics?

  • Chronic Pain
  • Opioid
  • Salicylic Acid
  • United States
  • Amgen Inc.

Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets

  • $ 4995
  • March 2017
  • 1 pages

Mild pain is treated with non-opioid analgesics such as acetaminophen and paracetamol, or nonsteroidal anti-inflammatory drugs (NSAID).

  • Blood Disease
  • Cancer
  • Salicylic Acid
  • Therapy
  • Amgen Inc.

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • August 2016
  • 416 pages

ALL PATIENTS RECEIVED STANDARD ASPIRIN THERAPY.

  • Epidemiology
  • Hospital
  • Salicylic Acid
  • Therapy
  • Amgen Inc.

Global Biosimilar Market: Size, Trends & Forecasts (2016-2020)

  • $ 800
  • November 2016
  • 58 pages

glycosylation) totally different from the one used when dealing with microbial cell lines. ##. ##. ## Difference between Chemical Drugs Vs ##st Gen Vs ##nd Gen Biologics ##. ## Overview of Biologics Chemical synthesis Biological process Biological process Oral form Injectables Injectables Aspirin,

  • Biosimilar
  • Salicylic Acid
  • Amgen Inc.
  • Celltrion, Inc.
  • Pfizer Inc.

Rheumatoid Arthritis Therapeutics in South-East Asia Markets to 2022 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs

  • $ 4995
  • April 2017
  • 1 pages

aspirin, diclofenac, ibuprofen and celecoxib are commonly recommended as symptomatic treatments for RA patients.

  • Monoclonal Antibody
  • Pharmaceutical
  • Salicylic Acid
  • Therapy
  • Amgen Inc.

Global Immunology Drugs Market to 2022 - Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth

  • $ 4995
  • June 2017
  • 140 pages

These include NSAIDs such as aspirin, diclofenac, ibuprofen and Celebrex (celecoxib), and analgesics (painkillers), such as codeine.

  • Autoimmune Disease
  • Immunology
  • Salicylic Acid
  • Therapy
  • Amgen Inc.

PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • April 2016
  • 307 pages

PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024 Summary Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence ...

  • Autoimmune Disease
  • Biosimilar
  • Salicylic Acid
  • Therapy
  • Amgen Inc.

Global Biosimilars Market and Forecast (By Product Type, Applications, Country Wise and Companies) to 2021 and Biosimilars Approved and Pipeline Analysis

  • $ 1350
  • October 2016
  • 177 pages

For example, aspirin, part of a common category of medicine known as small-molecule drugs, is made of up only ## atoms.

  • Biosimilar
  • Medical Biotechnology
  • Pharmaceutical
  • Salicylic Acid
  • Amgen Inc.

Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis

  • $ 6995
  • August 2017
  • 113 pages

However, evidence for the use of aspirin as a primary preventive method is mixed.

  • Cardiovascular Disease
  • Chronic Disease
  • Pathology
  • Salicylic Acid
  • Amgen Inc.

Global Rhematoid Arthritis Drugs Market 2016-2020

  • $ 2500
  • February 2016
  • 126 pages

2016-2020 TECHNAVIO.

  • Pharmaceutical
  • Salicylic Acid
  • Therapy
  • Amgen Inc.
  • Pfizer Inc.

Psoriasis - India Drug Forecast and Market Analysis to 2024

  • $ 4995
  • April 2016
  • 208 pages

Psoriasis - India Drug Forecast and Market Analysis to 2024 Summary Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. ...

  • Autoimmune Disease
  • Biosimilar
  • Monoclonal Antibody
  • Therapy
  • Amgen Inc.
View report >

The future of the Research And Development Industry

  • January 2019
  • 24 pages

The largest virtual clinical trial, the ADAPTABLE study with PCORI (the Patient Centered Outcomes Research Unit), was launched in 2014, and examines the impact of aspirin dosage levels on patients with heart disease.

  • Research And Development
  • Salicylic Acid
  • World
  • Amgen Inc.
  • Pfizer Inc.

Pharmaceutical Markets January 2017

Therapy Market January 2017

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on